期刊文献+

乙型肝炎疫苗-卡介苗联合疫苗细胞免疫的研究 被引量:5

Cellular Immunity of Hepatitis B-BCG Combined Vaccine
暂未订购
导出
摘要 目的评价乙型肝炎疫苗-卡介苗联合疫苗对小鼠细胞免疫的影响。方法采用BALB/c小鼠,试验组分为联合疫苗组、卡介苗组、乙肝疫苗组,对照组分为空白组和保护剂组,各组小鼠分别于接种后1个月及2个月,取脾进行淋巴细胞转化试验以及细胞因子和T淋巴细胞表面标记检测。结果联合疫苗组淋巴细胞转化刺激指数、IL-2含量均明显高于卡介苗组和乙肝疫苗组;CD4+/CD8+值高于单价乙肝疫苗组,而与卡介苗组差异无显著意义。结论乙型肝炎疫苗-卡介苗联合疫苗能有效地诱导细胞免疫。 Objective To evaluate the influence of Hepatitis B (HB)-BCG combined vaccine on the cellular immunity in mice. Methods Divide BALB/c mice into three test groups ( HB-BCG combined vaccine, BCG and HB vaccine), one blank control group(unimmunized) and one parallel control group (protective agent). Take the spleens of mice for lymphocyte transformation test and the determination of cytokine and T lymphocyte surface marker 1 and 2 months after immunization separately. Results Both the lymphocyte transformation stimulating index and IL-2 content of mice in HB-BCG combined vaccine group were significantly higher than those of BCG and HB vaccine groups. However, the CD4^+/CD8^+ value of HB-BCG combined vaccine group was significantly higber than that of HB vaccine group,but showed no significant difference from that of BCG group. Conclusion HB-BCG combined vaccine induced cellular immunity effectively.
出处 《中国生物制品学杂志》 CAS CSCD 2006年第2期171-173,共3页 Chinese Journal of Biologicals
基金 吉林省科技发展计划项目(20050402-1).
关键词 乙型肝炎疫苗 卡介苗 联合疫苗 细胞免疫 Hepatitis B vaccine BCG Combined vaccine Cellular immunity
  • 相关文献

参考文献9

  • 1Yuko K,Yung CY,Manabu M,et al.Enhancing antivity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine.Vaccine,1998,16(20):1982-1988.
  • 2Mayrink W,Genaro O,Silva JC,et al.Phase Ⅰ and Ⅱ open clinical trials of a vaccine against leishmania chagasi infections in dog.Mem Inst Oswaldo Cruz,1996,91 (6):695 -697.
  • 3Keisari Y,Seger M,Leng J,et al.IL-1,TNF-α and IL-2 production by peritoneal and spleen cell from schistosoma mansoni infected mice and its potentiation by perimmunization with schistosomal antigen and immunostimulants.Immunobiology,1993,188:446-459.
  • 4Li Q,Normolle DP,Sayre DM,et al.Immunological effects of BCG as an adjuvant in autologous tumor vaccines.Clin Immunol,2000,94(1):64-72.
  • 5Edelman R,Parmer K,Russ KG,et al.Safety and immunogenicity of recombinant bacille calmtte-guerin(rBCG) expression borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adjult volunteers:a candidate lyme disease vaccine.Vaccine,1999,17 (7-8):904-914.
  • 6Satti IN,Osman HY,Daifaalla NS,et al.Immumogenicity and safety of leishmanlia major plus BCG vaccine in healthy sudanese volunteers.Vaccine,2001,19(15-16):2100-2106.
  • 7Kremer L,Estaquier J,Wolowczuk I,et al.Ineffective cellular immune response associated with T-cell apoptosis in susceptible mycobacterium bovis BCG-infected mice.Infect Immun,2000,68 (7):4264-4273.
  • 8Ishikawa T,Kono D,Chung J.Polyclonality and multispecificity of the CTL response to a single viral epitope.J Immunol,1998,161(11):5842-5850.
  • 9Kurose K,Akbar SM,Yamamoto K,et al.Production of antibody to hepatitis B surface antigen(anti-HBs) by murine hepatitis B virus carriers:neonatal tolerance versus antigen presentation by dendritic cells.Immunology,1997,92 (4):494-500.

同被引文献44

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部